Registration open for "Claus per Bioemprendre" introductory course in bioentrepreneurship
<p>Top bioentrepreneurship in Catalonia will share their personal experiences with students and researchers on 15, 22 and 29 May</p>
Sharing the experiences of successful entrepreneurs in the healthcare arena helps raise awareness of role models for other researchers in the sector, encouraging them to choose entrepreneurship and, therefore, technology transfer. This is why Biocat organizes the 8th edition of the “Claus per Bioemprendre” introductory course in bioentrepreneurship to share the personal experiences of top bioentrepreneurs in Catalonia with students and researchers.
“Claus per Bioemprendre” is geared towards graduates and undergraduate students in the life sciences (biology, pharmacy, biotechnology, medicine, biochemistry, veterinary, chemistry), masters and PhD students and young researchers. Next edition will take place in three sessions held on 15, 22 and 29 May 2018. The deadline for registration is 11th May.
The course has three three-hour sessions, covering the role of entrepreneurship in biotechnology; the first steps in bioentrepreneurship, from concept to first rounds of funding; and the phases and partners that make up the life cycle of a biotechnology company.
This edition will feature:
- Lluis Ruiz-Ávila, CEO of Spherium Biomed
- Laura Soucek, Founder and CEO of Peptomyc
- Marc Ramis, Co-founder and CEO of Senolytic Therapeutics
- Lluís Pareras, Director of HealthEquity SCR
- Christian Brander, Co-founder and Scientific Director of Aelix Therapeutics
- Judit Anido, Co-founder and General Manager of Mosaic Biomedicals
- Montserrat Vendrell, Partner of Alta Life Sciences
- Ignasi Costas, Partner of RCD-Rousaud Costas Duran
- Marc Martinell, Founder and CEO of Minoryx Therapeutics
- Jordi Naval, Director of Strategy of Biocat (Moderator)
See the Full Program here (in Catalan).
“In this course, successful bioentrepreneurs share their personal experiences, their passion for entrepreneurship, starting a new project and creating value for society,” highlights Biocat Director of Strategy Jordi Naval. “You’ll get a first-hand look at the successes, failures, issues and satisfactions of bioentrepreneurship.”
The course is possible thanks to the collaboration of Associació de Biotecnòlegs de Catalunya and CataloniaBio & HealthTech, and the support from the Dr. Antoni Esteve Foundation.
With the support of*:
* With the support of the Department of Enterprise and Knowledge and the co-financing of the ESF